Crossmark

Screening antiproliferative drug for breast cancer from bisbenzylisoquinoline alkaloid tetrandrine and fangchinoline derivatives by targeting BLM helicase

Crossref DOI link: https://doi.org/10.1186/s12885-019-6146-7

Published Online: 2019-10-28

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Wangming

Yang, Shuang

Liu, Jinhe

Bao, Linchun

Lu, He

Li, Hong

Pan, Weidong

Jiao, Yanchao

He, Zhixu

Liu, Jielin http://orcid.org/0000-0002-1982-2587
Funding

Funding for this research was provided by:

Science and Technology Department of Guizhou Province (QKHJZDZ[2015]2003, QSZHZ[2006]57, QKHWGZ [2011]7012, QKHLHZ[2015]7282)

National Natural Science Foundation of China (No. 81360349, No.81360479)
License Information

Text and Data Mining valid from 2019-10-28

Version of Record valid from 2019-10-28
More Information

Article History

Received: 3 July 2018

Accepted: 10 September 2019

First Online: 28 October 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below